NCT05045833View on ClinicalTrials.gov

Multiple Ascending Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered SYN 020

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 18, 2021

Primary Completion Date

February 22, 2022

Study Completion Date

March 21, 2022

Conditions
Enteritis Caused by Radiation
Interventions
DRUG

SYN-020 Delayed Release Capsule

Oral administration (by mouth)

Trial Locations (1)

53095

Spaulding Clinical Research LLC, West Bend

All Listed Sponsors
collaborator

Spaulding Clinical Research LLC

OTHER

lead

Theriva Biologics, Inc.

INDUSTRY

NCT05045833 - Multiple Ascending Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered SYN 020 | Biotech Hunter | Biotech Hunter